Cargando…
Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients
BACKGROUND: Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060770/ https://www.ncbi.nlm.nih.gov/pubmed/33959257 http://dx.doi.org/10.1177/20458940211007040 |
_version_ | 1783681433526599680 |
---|---|
author | Wats, Karan Rodriguez, Daniel Prins, Kurt W. Sadiq, Adnan Fogel, Joshua Goldberger, Mark Moskovits, Manfred Tootkaboni, Mahsa Pourabdollah Shani, Jacob Jacob, Jessen |
author_facet | Wats, Karan Rodriguez, Daniel Prins, Kurt W. Sadiq, Adnan Fogel, Joshua Goldberger, Mark Moskovits, Manfred Tootkaboni, Mahsa Pourabdollah Shani, Jacob Jacob, Jessen |
author_sort | Wats, Karan |
collection | PubMed |
description | BACKGROUND: Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day clinical outcomes secondary to COVID-19 hospitalization. METHODS: This retrospective cohort study was conducted in a large tertiary hospital in New York City during the COVID-19 pandemic. It included 214 adult inpatients with a laboratory-confirmed diagnosis of COVID-19 by reverse transcriptase polymerase chain reaction assay (RT-PCR) for SARS-CoV-2 on nasopharyngeal swab and had a transthoracic echocardiogram performed during the index hospitalization. Primary outcome was 30-day all-cause inpatient mortality. Secondary outcomes were 30-day utilization of mechanical ventilator support, vasopressors, or renal replacement therapy. RESULTS: Mild right ventricular systolic dysfunction (odds ratio (OR): 3.51, 95% confidence interval (CI): 1.63–7.57, p = 0.001), moderate to severe right ventricular systolic dysfunction (OR: 7.30, 95% CI: 2.20–24.25, p = 0.001), pulmonary hypertension (OR: 5.39, 95% CI: 1.96–14.86, p = 0.001), and moderate to severe tricuspid regurgitation (OR: 3.92, 95% CI: 1.71–9.03, p = 0.001) were each associated with increased odds of 30-day all-cause inpatient mortality. Pulmonary hypertension and moderate to severe right ventricular dysfunction were each associated with increased odds of 30-day utilization of mechanical ventilator support and vasopressors. CONCLUSIONS: Right ventricular dysfunction, pulmonary hypertension, and moderate to severe tricuspid regurgitation were associated with increased odds for 30-day inpatient mortality. This study highlights the importance of echocardiography and its clinical utility and prognostic value for evaluating hospitalized COVID-19 patients. |
format | Online Article Text |
id | pubmed-8060770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80607702021-05-05 Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients Wats, Karan Rodriguez, Daniel Prins, Kurt W. Sadiq, Adnan Fogel, Joshua Goldberger, Mark Moskovits, Manfred Tootkaboni, Mahsa Pourabdollah Shani, Jacob Jacob, Jessen Pulm Circ Original Research Article BACKGROUND: Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day clinical outcomes secondary to COVID-19 hospitalization. METHODS: This retrospective cohort study was conducted in a large tertiary hospital in New York City during the COVID-19 pandemic. It included 214 adult inpatients with a laboratory-confirmed diagnosis of COVID-19 by reverse transcriptase polymerase chain reaction assay (RT-PCR) for SARS-CoV-2 on nasopharyngeal swab and had a transthoracic echocardiogram performed during the index hospitalization. Primary outcome was 30-day all-cause inpatient mortality. Secondary outcomes were 30-day utilization of mechanical ventilator support, vasopressors, or renal replacement therapy. RESULTS: Mild right ventricular systolic dysfunction (odds ratio (OR): 3.51, 95% confidence interval (CI): 1.63–7.57, p = 0.001), moderate to severe right ventricular systolic dysfunction (OR: 7.30, 95% CI: 2.20–24.25, p = 0.001), pulmonary hypertension (OR: 5.39, 95% CI: 1.96–14.86, p = 0.001), and moderate to severe tricuspid regurgitation (OR: 3.92, 95% CI: 1.71–9.03, p = 0.001) were each associated with increased odds of 30-day all-cause inpatient mortality. Pulmonary hypertension and moderate to severe right ventricular dysfunction were each associated with increased odds of 30-day utilization of mechanical ventilator support and vasopressors. CONCLUSIONS: Right ventricular dysfunction, pulmonary hypertension, and moderate to severe tricuspid regurgitation were associated with increased odds for 30-day inpatient mortality. This study highlights the importance of echocardiography and its clinical utility and prognostic value for evaluating hospitalized COVID-19 patients. SAGE Publications 2021-04-19 /pmc/articles/PMC8060770/ /pubmed/33959257 http://dx.doi.org/10.1177/20458940211007040 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Wats, Karan Rodriguez, Daniel Prins, Kurt W. Sadiq, Adnan Fogel, Joshua Goldberger, Mark Moskovits, Manfred Tootkaboni, Mahsa Pourabdollah Shani, Jacob Jacob, Jessen Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients |
title | Association of right ventricular dysfunction and pulmonary
hypertension with adverse 30-day outcomes in COVID-19 patients |
title_full | Association of right ventricular dysfunction and pulmonary
hypertension with adverse 30-day outcomes in COVID-19 patients |
title_fullStr | Association of right ventricular dysfunction and pulmonary
hypertension with adverse 30-day outcomes in COVID-19 patients |
title_full_unstemmed | Association of right ventricular dysfunction and pulmonary
hypertension with adverse 30-day outcomes in COVID-19 patients |
title_short | Association of right ventricular dysfunction and pulmonary
hypertension with adverse 30-day outcomes in COVID-19 patients |
title_sort | association of right ventricular dysfunction and pulmonary
hypertension with adverse 30-day outcomes in covid-19 patients |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060770/ https://www.ncbi.nlm.nih.gov/pubmed/33959257 http://dx.doi.org/10.1177/20458940211007040 |
work_keys_str_mv | AT watskaran associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT rodriguezdaniel associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT prinskurtw associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT sadiqadnan associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT fogeljoshua associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT goldbergermark associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT moskovitsmanfred associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT tootkabonimahsapourabdollah associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT shanijacob associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients AT jacobjessen associationofrightventriculardysfunctionandpulmonaryhypertensionwithadverse30dayoutcomesincovid19patients |